Stay updated on Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial page.

Latest updates to the Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial page
- CheckyesterdayChange DetectedClinicalTrials.gov’s page footer updated the displayed application/version revision from v3.5.2 to v3.5.3 without changing the study record details.SummaryDifference0.1%

- Check8 days agoChange DetectedAdded Revision: v3.5.2 and Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; this is a system-level change with no visible impact on the study details or user-facing information.SummaryDifference0.1%

- Check72 days agoChange DetectedA minor site update adds Revision: v3.4.2 and removes Revision: v3.4.1, and an updated government funding/status notice is displayed. These changes do not affect the trial details, eligibility criteria, or results on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check79 days agoChange DetectedA site-wide government funding status notice was added and the page revision updated from v3.4.0 to v3.4.1. No study content or core details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial page.